Results 241 to 250 of about 105,732 (293)

Evaluation of Fibrinolysis by Thromboelastography in Dogs With Hemorrhagic Pericardial Effusion. [PDF]

open access: yesJ Vet Emerg Crit Care (San Antonio)
Ehrlich MR   +6 more
europepmc   +1 more source

Rather a versatile multi-tool than a sword: an integral role of the plasminogen system in health and disease. [PDF]

open access: yesFront Immunol
Skrabana R   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

tPA and warfarin

Neurology, 2013
The appropriate use of IV tissue plasminogen activator (tPA) for patients with acute ischemic stroke remains an area of active discussion among health care professionals. Since its approval in the United States by the Food and Drug Administration in 1996, the medical community has continued to review and discuss the risks vs benefits of this important ...
Mark J, Alberts, Andrew M, Naidech
openaire   +2 more sources

TPA: Is it worth the price?

American Heart Journal, 1987
What, then, are the relative merits of TPA and streptokinase? Existing evidence supports the concept that reperfusion rates are somewhat higher with TPA, particularly after 4 hours when streptokinase is relatively ineffective but the degree of myocardial salvage is likely to be small. Streptokinase has the major advantage of a proven track record, both
openaire   +2 more sources

Phorbol ester induced prostaglandin synthesis and [3H]-TPA metabolism by TPA-sensitive and TPA-resistant friend erythroleukemia cells

Biochemical and Biophysical Research Communications, 1979
Abstract The potent mouse skin tumour promoter, 12-O-tetra-decanoyl phorbol-13-acetate (TPA), causes a release of arachidonic acid and prostaglandins E2 and F2α from Friend erythroleukemia cells (FELC). This effect is not seen with a subclone which is resistant to both TPA-induced inhibition of differentiation and TPA-induced adhesion.
H, Yamasaki, R A, Mufson, I B, Weinstein
openaire   +2 more sources

Home - About - Disclaimer - Privacy